MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 11, 2022

Total Value ($000): $548,527 (100.0% shares, 0.0% debt)

Holdings (33)

CGEM Cullinan Oncology, Inc. 21.5%
Value ($000) $118,013 Shares 7,648,268 Est. Cost $40.60 Unrealized -50.9%
iTeos Therapeutics, Inc. 15.7%
Value ($000) $85,890 Shares 1,844,727 Est. Cost $24.67 Unrealized
Repare Therapeutics, Inc. 6.3%
Value ($000) $34,584 Shares 1,639,849 Est. Cost $31.02 Unrealized
MEI Pharma, Inc. 6.0%
Value ($000) $32,977 Shares 12,350,971 Est. Cost $2.67 Unrealized
Merus N.V. 5.4%
Value ($000) $29,488 Shares 927,302 Est. Cost $17.60 Unrealized
HOWL Werewolf Therapeutics, Inc. 5.2%
Value ($000) $28,441 Shares 2,388,011 Est. Cost $13.70 Unrealized +10.2%
Harpoon Therapeutics, Inc. 4.4%
Value ($000) $24,135 Shares 3,196,707 Est. Cost $14.79 Unrealized
NTLA Intellia Therapeutics, Inc. 3.5%
Value ($000) $18,981 Shares 160,527 Est. Cost $151.40 Unrealized -17.3%
TCR2 Therapeutics, Inc. 2.9%
Value ($000) $15,709 Shares 3,370,982 Est. Cost $14.28 Unrealized
Turning Point Therapeutics, Inc. 2.4%
Value ($000) $12,943 Shares 271,350 Est. Cost $44.66 Unrealized
Oncorus, Inc. 2.3%
Value ($000) $12,527 Shares 2,377,031 Est. Cost $32.33 Unrealized
CRNX Crinetics Pharmaceuticals Inc. 2.0%
Value ($000) $10,790 Shares 379,792 Est. Cost $21.72 Unrealized +13.5%
CYTK Cytokinetics Inc. 1.9%
Value ($000) $10,587 Shares 232,268 Est. Cost $29.44 Unrealized +31.1%
ESSA Pharma, Inc. 1.7%
Value ($000) $9,495 Shares 668,688 Est. Cost $8.00 Unrealized
BCRX Biocryst Pharmaceuticals Inc. 1.7%
Value ($000) $9,168 Shares 661,951 Est. Cost $15.77 Unrealized -16.1%
TVTX Travere Therapeutics Inc. 1.6%
Value ($000) $8,936 Shares 287,893 Est. Cost $18.37 Unrealized +53.3%
G1 Therapeutics, Inc. 1.6%
Value ($000) $8,748 Shares 856,798 Est. Cost $25.71 Unrealized
Epizyme, Inc. 1.6%
Value ($000) $8,563 Shares 3,425,202 Est. Cost $15.19 Unrealized
YmAbs Therapeutics, Inc. 1.3%
Value ($000) $7,237 Shares 446,457 Est. Cost $30.56 Unrealized
GERN Geron Corporation 1.3%
Value ($000) $6,861 Shares 5,623,889 Est. Cost $1.33 Unrealized +7.3%
ADCT ADC Therapeutics, Inc. 1.2%
Value ($000) $6,815 Shares 337,396 Est. Cost $33.59 Unrealized -28.2%
Verastem, Inc. 1.2%
Value ($000) $6,707 Shares 3,271,532 Est. Cost $2.94 Unrealized
HRMY Harmony Biosciences Hldgs Inc. 1.1%
Value ($000) $6,074 Shares 142,437 Est. Cost $32.20 Unrealized +23.8%
FOLD Amicus Therapeutics Inc. 1.1%
Value ($000) $5,929 Shares 513,333 Est. Cost $10.23 Unrealized +8.9%
NEO Neogenomics Inc. 0.9%
Value ($000) $4,791 Shares 140,422 Est. Cost $46.29 Unrealized -15.4%
MIRM Mirum Pharmaceuticals Inc. 0.9%
Value ($000) $4,767 Shares 298,852 Est. Cost $16.26 Unrealized -4.4%
AXSM Axsome Therapeutics Inc. 0.7%
Value ($000) $3,907 Shares 103,405 Est. Cost $38.97 Unrealized -5.6%
RVMD Revolution Medicines, Inc. 0.7%
Value ($000) $3,676 Shares 146,041 Est. Cost $29.11 Unrealized -3.2%
Avadel Pharmaceuticals Plc 0.6%
Value ($000) $3,033 Shares 375,326 Est. Cost $9.80 Unrealized
ACAD Acadia Pharmaceuticals Inc 0.5%
Value ($000) $2,918 Shares 125,000 Est. Cost $20.11 Unrealized 0.0%
AVROBIO, Inc. 0.5%
Value ($000) $2,494 Shares 647,918 Est. Cost $5.58 Unrealized
Inozyme Pharma Inc. 0.4%
Value ($000) $2,064 Shares 302,615 Est. Cost $11.59 Unrealized
BDTX Black Diamond Therapeutics, Inc. 0.2%
Value ($000) $1,279 Shares 239,888 Est. Cost $9.87 Unrealized -29.3%